ES8607725A1 - Procedimiento para la obtencion de un preparado de combina- cion con biodisponibilidad mejorada - Google Patents

Procedimiento para la obtencion de un preparado de combina- cion con biodisponibilidad mejorada

Info

Publication number
ES8607725A1
ES8607725A1 ES543389A ES543389A ES8607725A1 ES 8607725 A1 ES8607725 A1 ES 8607725A1 ES 543389 A ES543389 A ES 543389A ES 543389 A ES543389 A ES 543389A ES 8607725 A1 ES8607725 A1 ES 8607725A1
Authority
ES
Spain
Prior art keywords
nifedipin
combinations
manufacturing process
nifedipine
blockers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES543389A
Other languages
English (en)
Other versions
ES543389A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of ES8607725A1 publication Critical patent/ES8607725A1/es
Publication of ES543389A0 publication Critical patent/ES543389A0/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

PROCEDIMIENTO PARA OBTENER NUEVOS PREPARADOS DE NIFEDIPINA EN FORMA SOLIDA CON BIODISPONIBILIDAD MODIFICADA. COMPRENDE: A) HACER REACCIONAR A UN COMPUESTO ILIDENO D.F. (I) CON UN COMPUESTO DE ENAMINA D.F. (II) EN ALCOHOLES INFERIORES DE C 1 A 4, Y ENTRE 40 Y 100JC, PARA OBTENER NIFEDIPINA Y B) GRANULAR A LA NIFEDIPINA Y A LA SUSTANCIA ACTIVA B-BLOQUEADORA CON AGENTES AUXILIARES Y EXCIPIENTES EN VIA HUMEDA. LOS AGENTES AUXILIARES SE ELIGEN ENTRE FECULAS DERIVADAS DE CELULOSA ESTEARATO DE CALCIO, PARAFINA O TALCO Y LA SUSTANCIA B-BLOQUEADORA SE ELIGE ENTRE ACEBUTOLOL, ATENOLOL Y NADALOL Y LOS EXCIPIENTES SE ELIGEN SO4CA O CO3CA. SE UTILIZA COMO MEDIO CORONARIO Y PARA REGULAR LA PRESION SANGUINEA.
ES543389A 1984-05-23 1985-05-22 Procedimiento para la obtencion de un preparado de combina- cion con biodisponibilidad mejorada Expired ES8607725A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843419130 DE3419130A1 (de) 1984-05-23 1984-05-23 Nifedipinkombinationspraeparate und verfahren zu ihrer herstellung

Publications (2)

Publication Number Publication Date
ES8607725A1 true ES8607725A1 (es) 1986-06-01
ES543389A0 ES543389A0 (es) 1986-06-01

Family

ID=6236598

Family Applications (1)

Application Number Title Priority Date Filing Date
ES543389A Expired ES8607725A1 (es) 1984-05-23 1985-05-22 Procedimiento para la obtencion de un preparado de combina- cion con biodisponibilidad mejorada

Country Status (14)

Country Link
EP (1) EP0165450A3 (es)
JP (1) JPS60255724A (es)
KR (1) KR850008619A (es)
CN (1) CN85101820A (es)
AU (1) AU4280785A (es)
DD (1) DD237114A5 (es)
DE (1) DE3419130A1 (es)
DK (1) DK228085A (es)
ES (1) ES8607725A1 (es)
GR (1) GR851218B (es)
HU (1) HUT38252A (es)
IL (1) IL75244A0 (es)
PT (1) PT80500B (es)
ZA (1) ZA853878B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3427402A1 (de) * 1984-07-25 1986-01-30 Bayer Ag, 5090 Leverkusen Neues kombinationspraeparat, verfahren zu seiner herstellung und seine verwendung als arzneimittel
FR2577802B1 (fr) * 1985-02-26 1987-07-24 Synthelabo Compositions pharmaceutiques a base de betaxolol et de nifedipine
DE3610037A1 (de) * 1986-03-21 1987-09-24 Schering Ag Nifedipinkombinationspraeparat
DE3829398A1 (de) * 1988-08-30 1990-03-08 Rentschler Arzneimittel Fixe arzneimittelkombination mit verzoegerter freisetzung
WO1993000081A1 (en) * 1991-06-28 1993-01-07 Sepracor, Inc. Optically pure s(-) nadolol for treatment of cardiovascular disorders

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1670827C3 (de) * 1967-03-20 1974-10-24 Bayer Ag, 5090 Leverkusen 4-(2'-Nitrophenyl)-2,6-dimethyl-3,5-dicarbmethoxy-1,4-dihydropyridin
SU432703A3 (es) * 1971-08-24 1974-06-15 Фридрих Боссерт, Вульф Фатер, Курт Бауер
DE2400819C2 (de) * 1974-01-09 1982-04-22 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung fester Zubereitungen von schwerlöslichen Arzneimittelwirkstoffen in feinster Verteilung
GB1579818A (en) * 1977-06-07 1980-11-26 Yamanouchi Pharma Co Ltd Nifedipine-containing solid preparation composition
EP0001247A1 (en) * 1977-09-14 1979-04-04 Kanebo, Ltd. Pharmaceutical preparation containing nifedipine and a method for producing the same.

Also Published As

Publication number Publication date
HUT38252A (en) 1986-05-28
KR850008619A (ko) 1985-12-21
DK228085A (da) 1985-11-24
DD237114A5 (de) 1986-07-02
ES543389A0 (es) 1986-06-01
PT80500B (en) 1987-04-21
AU4280785A (en) 1985-11-28
CN85101820A (zh) 1987-01-10
GR851218B (es) 1985-11-25
JPS60255724A (ja) 1985-12-17
PT80500A (en) 1985-06-01
EP0165450A2 (de) 1985-12-27
IL75244A0 (en) 1985-09-29
EP0165450A3 (de) 1986-03-12
DK228085D0 (da) 1985-05-22
ZA853878B (en) 1986-01-29
DE3419130A1 (de) 1985-11-28

Similar Documents

Publication Publication Date Title
DE3860503D1 (de) 10-dihydro-10-deoxo-11-azaerythronolid-a-verbindungen,verfahren und zwischenprodukte zu ihrer herstellung und ihre verwendung in arzneimitteln und in deren herstellung.
IE893712L (en) Quinuclidines, their use as medicaments and processes for¹their preparation
AR245159A1 (es) Un material laminar, articulos conformados con dicho material laminar y el metodo para producir dicho material laminar.
AU6884687A (en) Indolizine derivatives, process for preparing them and the compositions containing them
DE3869205D1 (de) 2-phenylpurinon-derivate, verfahren zu ihrer herstellung, ihre verwendung sowie zwischenprodukte.
HUT49605A (en) Insecticides and acaricides comprising n-amino-1,2,4-triazinone deriatives and process for producing the actie ingredients
HUT44415A (en) Fungicides comprising alpha-aryl-alpha-phenyl-ethyl-1h 1,2,4 triazole-1-propanenitrile derivatives as active substance and process for preparing the active substance
EP0254583A3 (en) Parasiticidal milbemicyn derivatives, a process for their production, and compositions containing the same
HUT44908A (en) Fungicides comprising triazolyl- or imidazolyl-group-substituted 2,5-dihydrofuran derivatives as active ingredient and process for producing the active ingredient and intermediaries thereof
EP0167909A3 (en) Solid pharmaceutical preparations containing dihydropyridines, and process for their manufacture
DE3872620D1 (de) (arylsulphonyl)-nitromethane, verfahren zu deren herstellung und deren verwendung in pharmazeutischen zusammensetzungen.
ES8607015A1 (es) Preparado solido de dihidropiridina
DE3577199D1 (de) Semicarbazidderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
ES8607017A1 (es) Preparado solido en combinacion de dihidropiridina
DE3868038D1 (de) Pulvermetallurgisch hergestellter schnellarbeitsstahl, daraus hergestellter versschleissteil und verfahren zu seiner herstellung.
IL85195A0 (en) Benzoylurea derivative,its production and insecticide composition containing the same
IT8820399A0 (it) Macchina per la produzione di contenitori.
ES8607725A1 (es) Procedimiento para la obtencion de un preparado de combina- cion con biodisponibilidad mejorada
EG19424A (en) Flavolignan derivatives, process for their preparation.
ES8607016A1 (es) Preparado solido de nifedipina
HUT71793A (en) 2,4-diamino-3-hydroxy-carboxylic acid derivatives, pharmaceutical compns. contg. them and process for producing the said compds.
AU585207B2 (en) Hydantoin derivatives, process for producing the same and medicine containing the same.
ZA898775B (en) Cyclopropyl-substituted azolylmethylcarbinols,processes for their preparation and their use as medicaments
HUT49873A (en) Herbicides and acaricides, as well as process for producing the active ingredient aryl- or heteroaryldione derivatives
HUT45513A (en) Process for producing bis(tertiary-butylamino)-1,3,5-triazine derivatives and pharmaceutics comprising the same as active ingredient